George Ayoub

George Ayoub is a board member at Nammi Therapeutics and has over 40 years of experience in the medical field. George has held various positions including president/CEO of One Lambda, Inc., a Thermo Fisher Scientific brand, and researcher at UCLA Tissue Typing. In 2012, they helped with the integration of One Lambda, Inc. into Thermo Fisher Scientific as the new TDX for their specialty Diagnostics group. Ayoub has also authored and coauthored numerous scientific publications.

George Ayoub holds a biochemistry degree from the University of California, Los Angeles and an MBA from Pepperdine University with a focus in marketing and marketing management.